Physique Pharma CJC-1295 + Ipamorelin is a research-grade peptide combination supplied in sterile 3mL vials, with 5mg of each peptide per vial. This dual formulation is designed for laboratory research exploring growth hormone regulation, tissue repair, and cellular regeneration.

• CJC-1295: A growth hormone-releasing hormone (GHRH) analog studied for its ability to stimulate growth hormone secretion and support tissue repair.

• Ipamorelin: A selective growth hormone secretagogue researched for its stimulation of growth hormone release with minimal effect on cortisol or prolactin levels.

Each vial is securely sealed to maintain sterility and ensure stable, reliable use for experimental studies.

Key Features:

• ⚗️ 5mg + 5mg – 3mL vial combining two peptides for advanced research applications.

• 💧 Sterile, research-grade formulation ensuring purity and consistency.

• 🔬 Supports studies on growth hormone release, tissue repair, and cellular regeneration.

• 🧴 Sealed vial maintains peptide stability and integrity.

• 🇦🇺 Australian supplied – trusted quality from Physique Pharma.

Intended Use:

CJC-1295 + Ipamorelin is intended for laboratory research purposes only. Typical research applications include:

• Studying growth hormone secretion and regulatory pathways.

• Investigating tissue repair, cellular regeneration, and metabolic processes.

• Supporting advanced peptide research and experimental studies.

Not for human or animal use.

Physique Pharma – Precision, purity, and dual-peptide research reliability.